From the Journals

Stem cells gene edited to be HIV resistant treat ALL, but not HIV

Publish date: September 11, 2019

 

FROM NEW ENGLAND JOURNAL OF MEDICINE

SOURCE: Xu L et al. N Engl J Med. 2019. doi: 10.1056/NEJMoa1817426.

Pages

Recommended Reading

Infections may trigger leukemia in the genetically susceptible
Federal Practitioner
FDA approves first gene therapy – tisagenlecleucel for ALL
Federal Practitioner
A global snapshot of leukemia incidence
Federal Practitioner
Lab results may help predict complications in ALL treatment
Federal Practitioner
Could An Antibiotic Be the Next Great Oncologic Drug?
Federal Practitioner
Researchers consider R/R ALL drugs in the first-line setting
Federal Practitioner
ALL chemotherapy looks effective in mixed phenotype leukemia
Federal Practitioner
Creating CAR T-cell therapies for T-cell malignancies
Federal Practitioner